Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/20/2025

Lung Nodule Evaluation and Management

Introduction to Lung Nodule Management

  • The American College of Radiology recommends that nodules larger than 8 mm should undergo functional imaging or tissue diagnosis rather than continued CT surveillance alone, due to the increased risk of malignancy 1, 2, 3
  • The presence of irregular margins in a lung nodule is a high-risk morphologic feature that increases the probability of malignancy, making PET-CT appropriate for further characterization 1, 4

Diagnostic Accuracy of PET-CT

  • PET-CT has a sensitivity of 88-96% and specificity of 77-88% for differentiating benign from malignant nodules in the size range of interest 2

Risk Stratification

  • Upper lobe location of a lung nodule is associated with a higher risk of malignancy [1, @8@]
  • Nodules larger than 8 mm with a moderate pretest probability (5-65%) should undergo PET scanning before deciding on biopsy versus surveillance 7, 6

Management of Small Nodules

  • Solid nodules smaller than 6 mm have a less than 1% risk of malignancy and typically require no routine follow-up [2, @9@]
  • Ground-glass nodules that are stable can be followed with CT surveillance at extended intervals (every 2 years up to 5 years) 6

Importance of Nodule Characteristics

  • The combination of irregular margins, upper lobe location, and size larger than 1 cm creates sufficient concern to warrant functional imaging regardless of apparent stability 1, 4, 6
  • Stability for 2 years applies only to completely benign-appearing solid nodules, and irregular morphology overrides the stability criterion and mandates further evaluation 3, 4, 1